Clinical Study
Expression and Prognostic Significance of Wnt7a in Human Endometrial Carcinoma
Table 2
The expressional profile of Wnt7a in endometrial carcinoma and its precursor lesions.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
Proliferative endometrium versus carcinoma: 0.004; Secretory endometrium versus carcinoma: <0.001; Atrophic endometrium versus carcinoma: 0.002; Simple hyperplasia versus carcinoma: 0.002; Complex hyperplasia versus carcinoma: 0.004 and *Chi-square test. |